Dr. Melanie Köllmer is head of formulation development at RaDes. She has more than 10 years of experience in pharmaceutical and biomedical research. Her expertise lies in the implementation of development projects, from formulation design of semi-solid dosage forms in feasibility studies to clinical phase and process development.

She studied pharmacy at Philipps-University in Marburg, Germany, and received her PhD in drug delivery and tissue engineering from the University of Illinois at Chicago, USA, in the laboratory of Prof. Dr. Richard A. Gemeinhart, followed by a PostDoc at the Illinois Institute of Technology (IIT) in Prof. Dr. Eric Brey’s laboratory.

Subsequently, Melanie worked as a formulation scientist at Almirall Hermal. In close cooperation with analytical development as well as drug discovery, the IP and Regulatory Affairs departments, she worked extensively on the design of semi-solid formulations and the evaluation of new topical excipients and technology platforms. In particular, she made decisive contributions to the successful development of a stable aqueous tacrolimus cream (Patent WO2019233722).

She focuses on rational design, cosmetic optimization, and characterization of semi-solid formulations for small molecules and probiotics. A special focus is the use of modern rheological methods to optimize stability, manufacturing processes and user friendliness of formulations.

Melanie Köllmer is the author of currently nine publications in the field of drug delivery and in vitro performance testing and regularly gives presentations in the field of formulation development and rheology.